Literature DB >> 19430446

Small but tenacious: South Africa's health biotech sector.

Sara Al-Bader1, Sarah E Frew, Insiya Essajee, Victor Y Liu, Abdallah S Daar, Peter A Singer.   

Abstract

Despite a challenging business environment, entrepreneurial health biotech companies in South Africa are finding ways to succeed.

Mesh：

Year:  2009        PMID： 19430446     DOI： 10.1038/nbt0509-427

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


  7 in total

1.  South Africa--blazing a trail for African biotechnology.

Authors:  Marion Motari; Uyen Quach; Halla Thorsteinsdóttir; Douglas K Martin; Abdallah S Daar; Peter A Singer
Journal:  Nat Biotechnol       Date:  2004-12       Impact factor: 54.908

Review 2.  Biotechnology in South Africa.

Authors:  Thomas E Cloete; Louis H Nel; Jacques Theron
Journal:  Trends Biotechnol       Date:  2006-10-30       Impact factor: 19.536

3.  Rainbow biotech--South Africa's emerging sector.

Authors:  Sabine Louët
Journal:  Nat Biotechnol       Date:  2006-11-02       Impact factor: 54.908

4.  India's health biotech sector at a crossroads.

Authors:  Sarah E Frew; Rahim Rezaie; Stephen M Sammut; Monali Ray; Abdallah S Daar; Peter A Singer
Journal:  Nat Biotechnol       Date:  2007-04       Impact factor: 54.908

Review 5.  Brazilian health biotech--fostering crosstalk between public and private sectors.

Authors:  Rahim Rezaie; Sarah E Frew; Stephen M Sammut; Maya R Maliakkal; Abdallah S Daar; Peter A Singer
Journal:  Nat Biotechnol       Date:  2008-06       Impact factor: 54.908

6.  XDR-TB in South Africa: no time for denial or complacency.

Authors:  Jerome Amir Singh; Ross Upshur; Nesri Padayatchi
Journal:  PLoS Med       Date:  2007-01       Impact factor: 11.069

Review 7.  Chinese health biotech and the billion-patient market.

Authors:  Sarah E Frew; Stephen M Sammut; Alysha F Shore; Joshua K Ramjist; Sara Al-Bader; Rahim Rezaie; Abdallah S Daar; Peter A Singer
Journal:  Nat Biotechnol       Date:  2008-01       Impact factor: 54.908
  7 in total
  13 in total

1.  Global health or global wealth?

Authors:  Rahim Rezaie; Peter A Singer
Journal:  Nat Biotechnol       Date:  2010-09       Impact factor: 54.908

2.  South-South entrepreneurial collaboration in health biotech.

Authors:  Halla Thorsteinsdóttir; Christina C Melon; Monali Ray; Sharon Chakkalackal; Michelle Li; Jan E Cooper; Jennifer Chadder; Tirso W Saenz; Maria Carlota de Souza Paula; Wen Ke; Lexuan Li; Magdy A Madkour; Sahar Aly; Nefertiti El-Nikhely; Sachin Chaturvedi; Victor Konde; Abdallah S Daar; Peter A Singer
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

3.  Life sciences venture capital in emerging markets.

Authors:  Justin Chakma; Stephen M Sammut; Ajay Agrawal
Journal:  Nat Biotechnol       Date:  2013-03       Impact factor: 54.908

4.  Emergence of biopharmaceutical innovators in China, India, Brazil, and South Africa as global competitors and collaborators.

Authors:  Rahim Rezaie; Anita M McGahan; Sarah E Frew; Abdallah S Daar; Peter A Singer
Journal:  Health Res Policy Syst       Date:  2012-06-06

5.  Venture capital on a shoestring: Bioventures' pioneering life sciences fund in South Africa.

Authors:  Hassan Masum; Peter A Singer
Journal:  BMC Int Health Hum Rights       Date:  2010-12-13

6.  Science-based health innovation in sub-Saharan Africa.

Authors:  Sara Al-Bader; Hassan Masum; Ken Simiyu; Abdallah S Daar; Peter A Singer
Journal:  BMC Int Health Hum Rights       Date:  2010-12-13

7.  Can incubators work in Africa? Acorn Technologies and the entrepreneur-centric model.

Authors:  Justin Chakma; Hassan Masum; Peter A Singer
Journal:  BMC Int Health Hum Rights       Date:  2010-12-13

8.  Turning science into health solutions: KEMRI's challenges as Kenya's health product pathfinder.

Authors:  Ken Simiyu; Hassan Masum; Justin Chakma; Peter A Singer
Journal:  BMC Int Health Hum Rights       Date:  2010-12-13

9.  Divide and Conquer May Not Be the Optimal Approach to Retain the Desirable Estrogenic Attributes of the Cyclopia Nutraceutical Extract, SM6Met.

Authors:  M Mortimer; K Visser; D de Beer; E Joubert; A Louw
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

Review 10.  Opportunities and barriers to establishing a cell therapy programme in South Africa.

Authors:  Carlo Stephan Jackson; Michael S Pepper
Journal:  Stem Cell Res Ther       Date:  2013-05-29       Impact factor: 6.832
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.